United States Biotechnology & Medical Research

Adamas Pharmaceuticals Inc (ADMS)

Track

Track

Ticker: ADMS Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Shreedhar Vijay Chief Commercial Officer Officer
Transaction date
Planned sale
Price
133.96
Quantity 20,347 +11.0%
Value US$3,342,443
2.5
DEMSKI MARTHA J Non-Executive Director
Transaction date
Planned sale
Price
43.62
Quantity 92,982 +33.7%
Value US$2,895,988
Prentiss Christopher B Chief Financial Officer Officer
Transaction date
Sale
Price
168.30
Quantity 23,552 -45.9%
Value US$1,754,007
Shreedhar Vijay Chief Commercial Officer Officer
Transaction date
Sale
Price
5.50
Quantity 1,051 -0.6%
Value US$5,780
2.7
Papapetropoulos Spyridon Non-Executive Director
Transaction date
Purchase
Price
5.06
Quantity 5,975 +59.8%
Value US$30,234
Prentiss Christopher B Chief Financial Officer Officer
Transaction date
Sale
Price
6.36
Quantity 3,821 -5.0%
Value US$24,302
Shreedhar Vijay Chief Commercial Officer Officer
Transaction date
Planned sale
Price
6.39
Quantity 4,514 -4.5%
Value US$28,844
Prentiss Christopher B Chief Financial Officer Officer
Transaction date
Sale
Price
4.41
Quantity 2,630 -3.3%
Value US$11,598
Prentiss Christopher B Chief Financial Officer Officer
Transaction date
Sale
Price
3.21
Quantity 2,050 -2.5%
Value US$6,580
Prentiss Christopher B Chief Financial Officer
Transaction date
Sale
Price
5.92
Quantity 1,269 -1.8%
Value US$7,512
MERRIWEATHER ALFRED G Chief Financial Officer
Transaction date
Sale
Price
6.91
Quantity 1,584 -3.2%
Value US$10,945
Prentiss Christopher B Chief Accounting Officer
Transaction date
Sale
Price
6.00
Quantity 1,082 -2.2%
Value US$6,492
3.4
Rhodes Jennifer J CBO, GC & Compliance Officer
Transaction date
Planned sale
Price
5.35
Quantity 940 -1.5%
Value US$5,029
Went Gregory T Chief Executive Officer Executive Director
Transaction date
Sale
Price
7.99
Quantity 6,319 -3.5%
Value US$50,489
3.4
Rhodes Jennifer J CBO, GC & Compliance Officer
Transaction date
Sale
Price
7.99
Quantity 1,792 -5.4%
Value US$14,318
MERRIWEATHER ALFRED G Chief Financial Officer
Transaction date
Sale
Price
7.99
Quantity 857 -3.4%
Value US$6,847
Prentiss Christopher B Chief Accounting Officer
Transaction date
Sale
Price
8.00
Quantity 1,185 -3.9%
Value US$9,480
Patni Rajiv Chief Medical Officer
Transaction date
Sale
Price
8.00
Quantity 2,374 -11.0%
Value US$18,992
Prentiss Christopher B Chief Accounting Officer Officer
Transaction date
Planned sale
Price
7.51
Quantity 228 -1.2%
Value US$1,712
Rhodes Jennifer J CBO, GC & Compliance Officer Officer
Transaction date
Planned sale
Price
7.52
Quantity 425 -1.3%
Value US$3,196
Went Gregory T Chief Executive Officer Executive Director
Transaction date
Purchase
Price
12.98
Quantity 3,850 +2.0%
Value US$49,956
MERRIWEATHER ALFRED G Chief Financial Officer Officer
Transaction date
Sale
Price
19.18
Quantity 1,665 -6.1%
Value US$31,935
Rhodes Jennifer J CBO, GC & Compliance Officer Officer
Transaction date
Planned sale
Price
25.48
Quantity 1,002 -2.9%
Value US$25,531
KING RICHARD Chief Operating Officer
Transaction date
Planned sale
Price
25.48
Quantity 2,501 -4.9%
Value US$63,725
Rhodes Jennifer J CBO, GC & Compliance Officer
Transaction date
Sale
Price
25.89
Quantity 982 -2.8%
Value US$25,424
Went Gregory T Chief Executive Officer Executive Director
Transaction date
Sale
Price
25.75
Quantity 4,541 -2.4%
Value US$116,931
Prentiss Christopher B Chief Accounting Officer
Transaction date
Sale
Price
25.98
Quantity 567 -3.1%
Value US$14,731
Patni Rajiv Chief Medical Officer
Transaction date
Sale
Price
25.94
Quantity 1,252 -5.5%
Value US$32,477
Rhodes Jennifer J CBO, GC & Compliance Officer
Transaction date
Planned sale
Price
32.30
Quantity 440 -1.5%
Value US$14,212
Rhodes Jennifer J CBO, GC & Compliance Officer
Transaction date
Planned sale
Price
17.53
Quantity 1,041 -3.5%
Value US$18,254
GREAT POINT PARTNERS LLC Large shareholder
Transaction date
Sale
Price
17.44
Quantity 10,000 -0.4%
Value US$174,365
GREAT POINT PARTNERS LLC Large shareholder
Transaction date
Sale
Price
17.35
Quantity 20,000 -0.9%
Value US$346,934
GREAT POINT PARTNERS LLC Large shareholder
Transaction date
Sale
Price
17.05
Quantity 350,000 -13.5%
Value US$5,967,675
Patni Rajiv Chief Medical Officer
Transaction date
Sale
Price
17.04
Quantity 733 -5.1%
Value US$12,490
Went Gregory T Chief Executive Officer Executive Director
Transaction date
Sale
Price
17.03
Quantity 2,807 -1.7%
Value US$47,803
DAWSON WILLIAM J Chief Financial Officer Officer
Transaction date
Sale
Price
17.02
Quantity 716 -4.8%
Value US$12,186
MDV IX LP Large shareholder
Transaction date
Purchase
Price
16.81
Quantity 8,240 +0.2%
Value US$138,497
Ericson William W. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
16.81
Quantity 8,240 +0.2%
Value US$138,497
MDV IX LP Large shareholder
Transaction date
Purchase
Price
16.50
Quantity 200 +0.0%
Value US$3,300
Ericson William W. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
16.50
Quantity 200 +0.0%
Value US$3,300
MDV IX LP Large shareholder
Transaction date
Purchase
Price
16.43
Quantity 54,537 +1.4%
Value US$895,787
Ericson William W. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
16.43
Quantity 54,537 +1.4%
Value US$895,787
Ericson William W. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
15.56
Quantity 62,034 +1.6%
Value US$964,995
MDV IX LP Large shareholder
Transaction date
Purchase
Price
15.56
Quantity 62,034 +1.6%
Value US$964,995
Ericson William W. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
15.65
Quantity 22,342 +0.6%
Value US$349,735
MDV IX LP Large shareholder
Transaction date
Purchase
Price
15.65
Quantity 22,342 +0.6%
Value US$349,735
MDV IX LP Large shareholder
Transaction date
Purchase
Price
15.68
Quantity 60,846 +1.6%
Value US$954,065
Ericson William W. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
15.68
Quantity 60,846 +1.6%
Value US$954,065
Ericson William W. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
15.00
Quantity 7,200 +0.2%
Value US$107,980
MDV IX LP Large shareholder
Transaction date
Purchase
Price
15.00
Quantity 7,200 +0.2%
Value US$107,980
Ericson William W. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
14.75
Quantity 43,719 +1.2%
Value US$644,921
MDV IX LP Large shareholder
Transaction date
Purchase
Price
14.75
Quantity 43,719 +1.2%
Value US$644,921
McClure Natalie SVP, Product Development Officer
Transaction date
Planned sale
Price
18.50
Quantity 23,334 -73.7%
Value US$431,679
McClure Natalie SVP, Product Development Officer
Transaction date
Planned sale
Price
18.50
Quantity 12,666 -60.3%
Value US$234,321
MDV IX LP Large shareholder
Transaction date
Planned sale
Price
27.55
Quantity 3,100 -1.0%
Value US$85,408
Ericson William W. Non-Executive Director Large shareholder
Transaction date
Planned sale
Price
27.55
Quantity 3,100 -1.0%
Value US$85,408
McClure Natalie SVP, Product Development Officer
Transaction date
Planned sale
Price
18.95
Quantity 2,000 -70.4%
Value US$37,900
Ericson William W. Non-Executive Director Large shareholder
Transaction date
Planned sale
Price
18.02
Quantity 112,073 -24.7%
Value US$2,019,555
MDV IX LP Large shareholder
Transaction date
Planned sale
Price
18.02
Quantity 112,073 -24.7%
Value US$2,019,555
Went Gregory T Chief Executive Officer Executive Director Large shareholder
Transaction date
Planned sale
Price
18.00
Quantity 200 -0.1%
Value US$3,600
Went Gregory T Chief Executive Officer Executive Director Large shareholder
Transaction date
Planned sale
Price
18.00
Quantity 100 -0.3%
Value US$1,800
Went Gregory T Chief Executive Officer Executive Director Large shareholder
Transaction date
Planned sale
Price
18.00
Quantity 100 -0.0%
Value US$1,800
Went Gregory T Chief Executive Officer Executive Director Large shareholder
Transaction date
Planned sale
Price
18.00
Quantity 28 -0.1%
Value US$504
Went Gregory T Chief Executive Officer Executive Director Large shareholder
Transaction date
Planned sale
Price
18.00
Quantity 1,800 -0.5%
Value US$32,400
Went Gregory T Chief Executive Officer Executive Director Large shareholder
Transaction date
Planned sale
Price
18.01
Quantity 500 -2.4%
Value US$9,003
McClure Natalie SVP, Product Development Officer
Transaction date
Planned sale
Price
17.62
Quantity 2,000 -70.4%
Value US$35,240
Went Gregory T Chief Executive Officer Executive Director Large shareholder
Transaction date
Planned sale
Price
18.01
Quantity 2,400 -0.6%
Value US$43,212
Went Gregory T Chief Executive Officer Executive Director Large shareholder
Transaction date
Planned sale
Price
18.00
Quantity 900 -4.3%
Value US$16,200
Went Gregory T Chief Executive Officer Executive Director Large shareholder
Transaction date
Planned sale
Price
18.00
Quantity 1,811 -0.5%
Value US$32,602
Went Gregory T Chief Executive Officer Executive Director Large shareholder
Transaction date
Planned sale
Price
18.01
Quantity 962 -4.6%
Value US$17,322
Went Gregory T Chief Executive Officer Executive Director Large shareholder
Transaction date
Planned sale
Price
18.00
Quantity 5,200 -1.3%
Value US$93,601
Went Gregory T Chief Executive Officer Executive Director Large shareholder
Transaction date
Planned sale
Price
18.00
Quantity 2,610 -11.5%
Value US$46,981
Went Gregory T Chief Executive Officer Executive Director Large shareholder
Transaction date
Planned sale
Price
18.00
Quantity 100 -0.0%
Value US$1,800
Went Gregory T Chief Executive Officer Executive Director Large shareholder
Transaction date
Planned sale
Price
18.00
Quantity 80 -0.8%
Value US$1,440
Went Gregory T Chief Executive Officer Executive Director Large shareholder
Transaction date
Planned sale
Price
19.07
Quantity 500 -0.1%
Value US$9,535
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2021-06-23 2021-06-21 PlS Planned sale
Shreedhar Vijay

Chief Commercial Officer

Officer
20,347 +11.0%
133.96
US$3,342,443 		20,347 +11.0% 133.96 US$3,342,443
2021-06-08 2021-06-07 PlS Planned sale
2.5
DEMSKI MARTHA J
Non-Executive Director
92,982 +33.7%
43.62
US$2,895,988 		92,982 +33.7% 43.62 US$2,895,988
2021-03-23 2021-03-22 S Sale
Prentiss Christopher B

Chief Financial Officer

Officer
23,552 -45.9%
168.30
US$1,754,007 		23,552 -45.9% 168.30 US$1,754,007
2021-03-23 2021-03-22 S Sale
Shreedhar Vijay

Chief Commercial Officer

Officer
1,051 -0.6%
5.50
US$5,780 		1,051 -0.6% 5.50 US$5,780
2021-03-15 2021-03-11 B Purchase
2.7
Papapetropoulos Spyridon
Non-Executive Director
5,975 +59.8%
5.06
US$30,234 		5,975 +59.8% 5.06 US$30,234
2021-02-01 2021-02-01 S Sale
Prentiss Christopher B

Chief Financial Officer

Officer
3,821 -5.0%
6.36
US$24,302 		3,821 -5.0% 6.36 US$24,302
2021-02-01 2021-02-01 PlS Planned sale
Shreedhar Vijay

Chief Commercial Officer

Officer
4,514 -4.5%
6.39
US$28,844 		4,514 -4.5% 6.39 US$28,844
2021-01-22 2021-01-20 S Sale
Prentiss Christopher B

Chief Financial Officer

Officer
2,630 -3.3%
4.41
US$11,598 		2,630 -3.3% 4.41 US$11,598
2020-11-02 2020-11-02 S Sale
Prentiss Christopher B

Chief Financial Officer

Officer
2,050 -2.5%
3.21
US$6,580 		2,050 -2.5% 3.21 US$6,580
2020-01-23 2020-01-21 S Sale
Prentiss Christopher B

Chief Financial Officer
1,269 -1.8%
5.92
US$7,512 		1,269 -1.8% 5.92 US$7,512
2019-09-23 2019-09-20 S Sale
MERRIWEATHER ALFRED G

Chief Financial Officer
1,584 -3.2%
6.91
US$10,945 		1,584 -3.2% 6.91 US$10,945
2019-07-23 2019-07-22 S Sale
Prentiss Christopher B

Chief Accounting Officer
1,082 -2.2%
6.00
US$6,492 		1,082 -2.2% 6.00 US$6,492
2019-06-21 2019-06-20 PlS Planned sale
3.4
Rhodes Jennifer J

CBO, GC & Compliance Officer
940 -1.5%
5.35
US$5,029 		940 -1.5% 5.35 US$5,029
2019-03-21 2019-03-20 S Sale
Went Gregory T

Chief Executive Officer

Executive Director
6,319 -3.5%
7.99
US$50,489 		6,319 -3.5% 7.99 US$50,489
2019-03-21 2019-03-20 S Sale
3.4
Rhodes Jennifer J

CBO, GC & Compliance Officer
1,792 -5.4%
7.99
US$14,318 		1,792 -5.4% 7.99 US$14,318
2019-03-21 2019-03-20 S Sale
MERRIWEATHER ALFRED G

Chief Financial Officer
857 -3.4%
7.99
US$6,847 		857 -3.4% 7.99 US$6,847
2019-03-21 2019-03-20 S Sale
Prentiss Christopher B

Chief Accounting Officer
1,185 -3.9%
8.00
US$9,480 		1,185 -3.9% 8.00 US$9,480
2019-03-21 2019-03-20 S Sale
Patni Rajiv

Chief Medical Officer
2,374 -11.0%
8.00
US$18,992 		2,374 -11.0% 8.00 US$18,992
2018-12-26 2018-12-20 PlS Planned sale
Prentiss Christopher B

Chief Accounting Officer

Officer
228 -1.2%
7.51
US$1,712 		228 -1.2% 7.51 US$1,712
2018-12-21 2018-12-20 PlS Planned sale Rhodes Jennifer J

CBO, GC & Compliance Officer

Officer
425 -1.3%
7.52
US$3,196 		425 -1.3% 7.52 US$3,196
2018-11-08 2018-11-07 B Purchase Went Gregory T

Chief Executive Officer

Executive Director
3,850 +2.0%
12.98
US$49,956 		3,850 +2.0% 12.98 US$49,956
2018-09-21 2018-09-21 S Sale
MERRIWEATHER ALFRED G

Chief Financial Officer

Officer
1,665 -6.1%
19.18
US$31,935 		1,665 -6.1% 19.18 US$31,935
2018-06-22 2018-06-21 PlS Planned sale
Rhodes Jennifer J

CBO, GC & Compliance Officer

Officer
1,002 -2.9%
25.48
US$25,531 		1,002 -2.9% 25.48 US$25,531
2018-06-22 2018-06-21 PlS Planned sale KING RICHARD

Chief Operating Officer
2,501 -4.9%
25.48
US$63,725 		2,501 -4.9% 25.48 US$63,725
2018-03-22 2018-03-21 S Sale Rhodes Jennifer J

CBO, GC & Compliance Officer
982 -2.8%
25.89
US$25,424 		982 -2.8% 25.89 US$25,424
2018-03-22 2018-03-21 S Sale
Went Gregory T

Chief Executive Officer

Executive Director
4,541 -2.4%
25.75
US$116,931 		4,541 -2.4% 25.75 US$116,931
2018-03-22 2018-03-21 S Sale
Prentiss Christopher B

Chief Accounting Officer
567 -3.1%
25.98
US$14,731 		567 -3.1% 25.98 US$14,731
2018-03-22 2018-03-21 S Sale Patni Rajiv

Chief Medical Officer
1,252 -5.5%
25.94
US$32,477 		1,252 -5.5% 25.94 US$32,477
2017-12-21 2017-12-21 PlS Planned sale Rhodes Jennifer J

CBO, GC & Compliance Officer
440 -1.5%
32.30
US$14,212 		440 -1.5% 32.30 US$14,212
2017-06-22 2017-06-21 PlS Planned sale
Rhodes Jennifer J

CBO, GC & Compliance Officer
1,041 -3.5%
17.53
US$18,254 		1,041 -3.5% 17.53 US$18,254
2017-06-21 2017-06-21 S Sale GREAT POINT PARTNERS LLC Large shareholder
10,000 -0.4%
17.44
US$174,365 		10,000 -0.4% 17.44 US$174,365
2017-06-21 2017-06-20 S Sale GREAT POINT PARTNERS LLC Large shareholder
20,000 -0.9%
17.35
US$346,934 		20,000 -0.9% 17.35 US$346,934
2017-06-21 2017-06-19 S Sale GREAT POINT PARTNERS LLC Large shareholder
350,000 -13.5%
17.05
US$5,967,675 		350,000 -13.5% 17.05 US$5,967,675
2017-03-22 2017-03-21 S Sale Patni Rajiv

Chief Medical Officer
733 -5.1%
17.04
US$12,490 		733 -5.1% 17.04 US$12,490
2017-03-22 2017-03-21 S Sale
Went Gregory T

Chief Executive Officer

Executive Director
2,807 -1.7%
17.03
US$47,803 		2,807 -1.7% 17.03 US$47,803
2017-03-22 2017-03-21 S Sale DAWSON WILLIAM J

Chief Financial Officer

Officer
716 -4.8%
17.02
US$12,186 		716 -4.8% 17.02 US$12,186
2016-09-16 2016-09-16 B Purchase MDV IX LP Large shareholder
8,240 +0.2%
16.81
US$138,497 		8,240 +0.2% 16.81 US$138,497
2016-09-16 2016-09-16 B Purchase Ericson William W. Non-Executive Director Large shareholder
8,240 +0.2%
16.81
US$138,497 		8,240 +0.2% 16.81 US$138,497
2016-09-16 2016-09-15 B Purchase MDV IX LP Large shareholder
200 +0.0%
16.50
US$3,300 		200 +0.0% 16.50 US$3,300
2016-09-16 2016-09-15 B Purchase Ericson William W. Non-Executive Director Large shareholder
200 +0.0%
16.50
US$3,300 		200 +0.0% 16.50 US$3,300
2016-09-16 2016-09-14 B Purchase MDV IX LP Large shareholder
54,537 +1.4%
16.43
US$895,787 		54,537 +1.4% 16.43 US$895,787
2016-09-16 2016-09-14 B Purchase Ericson William W. Non-Executive Director Large shareholder
54,537 +1.4%
16.43
US$895,787 		54,537 +1.4% 16.43 US$895,787
2016-09-14 2016-09-13 B Purchase Ericson William W. Non-Executive Director Large shareholder
62,034 +1.6%
15.56
US$964,995 		62,034 +1.6% 15.56 US$964,995
2016-09-14 2016-09-13 B Purchase MDV IX LP Large shareholder
62,034 +1.6%
15.56
US$964,995 		62,034 +1.6% 15.56 US$964,995
2016-09-14 2016-09-12 B Purchase Ericson William W. Non-Executive Director Large shareholder
22,342 +0.6%
15.65
US$349,735 		22,342 +0.6% 15.65 US$349,735
2016-09-14 2016-09-12 B Purchase MDV IX LP Large shareholder
22,342 +0.6%
15.65
US$349,735 		22,342 +0.6% 15.65 US$349,735
2016-09-09 2016-09-07 B Purchase MDV IX LP Large shareholder
60,846 +1.6%
15.68
US$954,065 		60,846 +1.6% 15.68 US$954,065
2016-09-09 2016-09-07 B Purchase Ericson William W. Non-Executive Director Large shareholder
60,846 +1.6%
15.68
US$954,065 		60,846 +1.6% 15.68 US$954,065
2016-09-07 2016-09-06 B Purchase Ericson William W. Non-Executive Director Large shareholder
7,200 +0.2%
15.00
US$107,980 		7,200 +0.2% 15.00 US$107,980
2016-09-07 2016-09-06 B Purchase MDV IX LP Large shareholder
7,200 +0.2%
15.00
US$107,980 		7,200 +0.2% 15.00 US$107,980
2016-09-07 2016-09-02 B Purchase Ericson William W. Non-Executive Director Large shareholder
43,719 +1.2%
14.75
US$644,921 		43,719 +1.2% 14.75 US$644,921
2016-09-07 2016-09-02 B Purchase MDV IX LP Large shareholder
43,719 +1.2%
14.75
US$644,921 		43,719 +1.2% 14.75 US$644,921
2016-04-20 2016-04-18 PlS Planned sale McClure Natalie

SVP, Product Development

Officer
23,334 -73.7%
18.50
US$431,679 		23,334 -73.7% 18.50 US$431,679
2016-04-20 2016-04-18 PlS Planned sale McClure Natalie

SVP, Product Development

Officer
12,666 -60.3%
18.50
US$234,321 		12,666 -60.3% 18.50 US$234,321
2015-07-09 2015-07-08 PlS Planned sale MDV IX LP Large shareholder
3,100 -1.0%
27.55
US$85,408 		3,100 -1.0% 27.55 US$85,408
2015-07-09 2015-07-08 PlS Planned sale Ericson William W. Non-Executive Director Large shareholder
3,100 -1.0%
27.55
US$85,408 		3,100 -1.0% 27.55 US$85,408
2015-06-09 2015-06-05 PlS Planned sale McClure Natalie

SVP, Product Development

Officer
2,000 -70.4%
18.95
US$37,900 		2,000 -70.4% 18.95 US$37,900
2015-06-01 2015-05-29 PlS Planned sale Ericson William W. Non-Executive Director Large shareholder
112,073 -24.7%
18.02
US$2,019,555 		112,073 -24.7% 18.02 US$2,019,555
2015-06-01 2015-05-29 PlS Planned sale MDV IX LP Large shareholder
112,073 -24.7%
18.02
US$2,019,555 		112,073 -24.7% 18.02 US$2,019,555
2015-05-14 2015-05-14 PlS Planned sale Went Gregory T

Chief Executive Officer

Executive Director Large shareholder
200 -0.1%
18.00
US$3,600 		200 -0.1% 18.00 US$3,600
2015-05-14 2015-05-14 PlS Planned sale Went Gregory T

Chief Executive Officer

Executive Director Large shareholder
100 -0.3%
18.00
US$1,800 		100 -0.3% 18.00 US$1,800
2015-05-14 2015-05-13 PlS Planned sale Went Gregory T

Chief Executive Officer

Executive Director Large shareholder
100 -0.0%
18.00
US$1,800 		100 -0.0% 18.00 US$1,800
2015-05-14 2015-05-13 PlS Planned sale Went Gregory T

Chief Executive Officer

Executive Director Large shareholder
28 -0.1%
18.00
US$504 		28 -0.1% 18.00 US$504
2015-05-14 2015-05-12 PlS Planned sale Went Gregory T

Chief Executive Officer

Executive Director Large shareholder
1,800 -0.5%
18.00
US$32,400 		1,800 -0.5% 18.00 US$32,400
2015-05-14 2015-05-12 PlS Planned sale Went Gregory T

Chief Executive Officer

Executive Director Large shareholder
500 -2.4%
18.01
US$9,003 		500 -2.4% 18.01 US$9,003
2015-05-07 2015-05-05 PlS Planned sale McClure Natalie

SVP, Product Development

Officer
2,000 -70.4%
17.62
US$35,240 		2,000 -70.4% 17.62 US$35,240
2015-04-27 2015-04-23 PlS Planned sale Went Gregory T

Chief Executive Officer

Executive Director Large shareholder
2,400 -0.6%
18.01
US$43,212 		2,400 -0.6% 18.01 US$43,212
2015-04-27 2015-04-23 PlS Planned sale Went Gregory T

Chief Executive Officer

Executive Director Large shareholder
900 -4.3%
18.00
US$16,200 		900 -4.3% 18.00 US$16,200
2015-04-22 2015-04-21 PlS Planned sale Went Gregory T

Chief Executive Officer

Executive Director Large shareholder
1,811 -0.5%
18.00
US$32,602 		1,811 -0.5% 18.00 US$32,602
2015-04-22 2015-04-21 PlS Planned sale Went Gregory T

Chief Executive Officer

Executive Director Large shareholder
962 -4.6%
18.01
US$17,322 		962 -4.6% 18.01 US$17,322
2015-04-22 2015-04-20 PlS Planned sale Went Gregory T

Chief Executive Officer

Executive Director Large shareholder
5,200 -1.3%
18.00
US$93,601 		5,200 -1.3% 18.00 US$93,601
2015-04-22 2015-04-20 PlS Planned sale Went Gregory T

Chief Executive Officer

Executive Director Large shareholder
2,610 -11.5%
18.00
US$46,981 		2,610 -11.5% 18.00 US$46,981
2015-04-14 2015-04-14 PlS Planned sale Went Gregory T

Chief Executive Officer

Executive Director Large shareholder
100 -0.0%
18.00
US$1,800 		100 -0.0% 18.00 US$1,800
2015-04-14 2015-04-14 PlS Planned sale Went Gregory T

Chief Executive Officer

Executive Director Large shareholder
80 -0.8%
18.00
US$1,440 		80 -0.8% 18.00 US$1,440
2015-04-14 2015-04-10 PlS Planned sale Went Gregory T

Chief Executive Officer

Executive Director Large shareholder
500 -0.1%
19.07
US$9,535 		500 -0.1% 19.07 US$9,535
Explore more

More insider trading research around Adamas Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America